Thomas Kuntz

Biography

Publications

• Testosterone treatment impacts the intestinal microbiome of transgender individuals.

  Harris RM, Pace F, Kuntz TM, Morgan XC, Hyland P, Summers K, McDermott E, Blumen K, Watnick PI. mSphere 2024 Oct 29

• A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.

  Merryman RW, Redd RA, Freedman AS, Ahn IE, Brown JR, Crombie JL, Davids MS, Fisher DC, Jacobsen ED, Kim AI, LaCasce AS, Ng S, Odejide OO, Parry EM, Isufi I, Kline J, Cohen JB, Mehta-Shah N, Bartlett NL, Mei M, Kuntz TM, Wolff J, Rodig SJ, Armand P, Jacobson CA. Ann Hematol 2024

• A two-cohort study on the association between the gut microbiota and bone density, microarchitecture, and strength.

  Okoro PC, Orwoll ES, Huttenhower C, Morgan X, Kuntz TM, McIver LJ, Dufour AB, Bouxsein ML, Langsetmo L, Farsijani S, Kado DM, Pacifici R, Sahni S, Kiel DP. Front Endocrinol (Lausanne) 2025

• Metagenomic assessment of gut microbial communities and risk of severe COVID-19.

  Nguyen LH, Okin D, Drew DA, Battista VM, Jesudasen SJ, Kuntz TM, Bhosle A, Thompson KN, Reinicke T, Lo CH, Woo JE, Caraballo A, Berra L, Vieira J, Huang CY, Das Adhikari U, Kim M, Sui HY, Magicheva-Gupta M, McIver L, Goldberg MB, Kwon DS, Huttenhower C, Chan AT, Lai PS. Genome Med 2023 07 12

• Human threat learning is associated with gut microbiota composition.

  Oyarzun JP, Kuntz TM, Stussi Y, Karaman OT, Vranos S, Callaghan BL, Huttenhower C, LeDoux JE, Phelps EA. PNAS Nexus 2022